Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Carcinosarcoma × LY-2157299 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 1 Glioma 1 Carcinosarcoma 1 Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Carboplatin 2 Biopsy 2 trastuzumab deruxtecan 1 ribociclib 1 pelcitoclax 1 cobimetinib 1 ceralasertib 1 belinostat 1 atezolizumab 1 TIC10 compound 1 Paclitaxel 1 LY-2157299 1 Fulvestrant 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03206177 2024-08-07

Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary

University of Oklahoma

Phase 1 Completed

26 enrolled 13 charts

Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡